Japan regulator upholds Sucampo patent for constipation drug, rejects Sawai's challenge
Japan’s patent office has upheld a pharmaceutical patent covering a treatment for drug-induced constipation licensed by Viatris from US-based Sucampo Pharma GmbH, rejecting an invalidation bid by Japan’s top generics maker...To view the full article, register now.
Already a subscriber? Click here to view full article